Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

Genaissance Pharmaceuticals Inc
5 Science Park
New Haven,  CT  06511
United States
Telephone: (203) 773-1450
Fax: (203) 562-9377
URL: http://www.genaissance.com
Email: contact-us@genaissance.com

Genaissance Pharmaceuticals Incorporated (NASDAQ: GNSC) builds DNA-based therapeutic and diagnostic technologies. Its HAP (TM) Technology is used by many research firms to predict drug responses. The firm also offers DNA purification, custom assay, ADME/PK studies, and other clinical and applied genetics services. Genaissance launched in 1997 and went public in 2000. Over three-fourth of the leading pharmaceuticals have worked with Genaissance Pharmaceuticals. Genaissance Pharmaceuticals is headquartered in Connecticut.

Org. Type: Corporation Equity Type: Public
Company Status: Active Date Founded: 1997
Symbol: NASDAQ:GNSC

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.